Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

DSpace Repository

Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

Author: Peisen, Felix; Gerken, Annika; Hering, Alessa; Dahm, Isabel; Nikolaou, Konstantin; Gatidis, Sergios; Eigentler, Thomas K.; Amaral, Teresa; Moltz, Jan H.; Othman, Ahmed E.
Tübinger Autor(en):
Dahm, Isabel
Nikolaou, Konstantin
Gatidis, Sergios
Amaral, Teresa
Peisen, Felix Ludwig
Eigentler, Thomas
Published in: Cancers (2024), Bd. 16 (15), Article 2669
Verlagsangabe: Basel : Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers16152669
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)